These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19786325)

  • 1. Promiscuous modulation of ion channels by anti-psychotic and anti-dementia medications.
    Bianchi MT
    Med Hypotheses; 2010 Feb; 74(2):297-300. PubMed ID: 19786325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From ion channels to complex networks: magic bullet versus magic shotgun approaches to anticonvulsant pharmacotherapy.
    Bianchi MT; Pathmanathan J; Cash SS
    Med Hypotheses; 2009 Mar; 72(3):297-305. PubMed ID: 19046822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The h-channel: a potential channelopathy in epilepsy?
    Poolos NP
    Epilepsy Behav; 2005 Aug; 7(1):51-6. PubMed ID: 15961349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic scope of modulation of non-voltage-gated cation channels.
    Li S; Gosling M; Poll CT; Westwick J; Cox B
    Drug Discov Today; 2005 Jan; 10(2):129-37. PubMed ID: 15718162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic scope of modulation of non-voltage-gated cation channels.
    Li S; Gosling M; Poll CT; Westwick J; Cox B
    Drug Discov Today; 2004 Dec; 9(24):1045-54. PubMed ID: 15582793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of functional ion-channel tools by E3 targeting.
    Xu SZ; Zeng F; Lei M; Li J; Gao B; Xiong C; Sivaprasadarao A; Beech DJ
    Nat Biotechnol; 2005 Oct; 23(10):1289-93. PubMed ID: 16170312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting ligand-gated ion channels in neurology and psychiatry: is pharmacological promiscuity an obstacle or an opportunity?
    Bianchi MT; Botzolakis EJ
    BMC Pharmacol; 2010 Mar; 10():3. PubMed ID: 20196850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology.
    Dunlop J; Bowlby M; Peri R; Vasilyev D; Arias R
    Nat Rev Drug Discov; 2008 Apr; 7(4):358-68. PubMed ID: 18356919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common pathway for charge transport through voltage-sensing domains.
    Chanda B; Bezanilla F
    Neuron; 2008 Feb; 57(3):345-51. PubMed ID: 18255028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of voltage-gated sodium channels in sensory neurones.
    Docherty RJ; Farmer CE
    Handb Exp Pharmacol; 2009; (194):519-61. PubMed ID: 19655117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion channels as potential targets for the treatment of depression.
    Lodge NJ; Li YW
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):633-41. PubMed ID: 18729015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural products as tools for studies of ligand-gated ion channels.
    Strømgaard K
    Chem Rec; 2005; 5(4):229-39. PubMed ID: 16041746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential oils components as a new path to understand ion channel molecular pharmacology.
    de Araújo DA; Freitas C; Cruz JS
    Life Sci; 2011 Oct; 89(15-16):540-4. PubMed ID: 21620870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory ligand-gated ion channels as substrates for general anesthetic actions.
    Zeller A; Jurd R; Lambert S; Arras M; Drexler B; Grashoff C; Antkowiak B; Rudolph U
    Handb Exp Pharmacol; 2008; (182):31-51. PubMed ID: 18175085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-gated ion channels and gating modifier toxins.
    Catterall WA; Cestèle S; Yarov-Yarovoy V; Yu FH; Konoki K; Scheuer T
    Toxicon; 2007 Feb; 49(2):124-41. PubMed ID: 17239913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular approaches to receptors as targets for drug discovery.
    Herz JM; Thomsen WJ; Yarbrough GG
    J Recept Signal Transduct Res; 1997 Sep; 17(5):671-776. PubMed ID: 9292776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroreceptors and ion channels as the basis for drug action: past, present, and future.
    Narahashi T
    J Pharmacol Exp Ther; 2000 Jul; 294(1):1-26. PubMed ID: 10871290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of synaptic function by cGMP and cGMP-gated cation channels.
    Barnstable CJ; Wei JY; Han MH
    Neurochem Int; 2004 Nov; 45(6):875-84. PubMed ID: 15312982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I; Tsien RW
    Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of mechanogated membrane ion channels.
    Hamill OP; McBride DW
    Pharmacol Rev; 1996 Jun; 48(2):231-52. PubMed ID: 8804105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.